# EYDENZELT
> **BLA761377** · Biologics License Application · Sponsor: CELLTRION INC · Approved 2025-10-02
## Drug
- **FDA Application Number:** BLA761377
- **Application type:** Biologics License Application
- **Brand name:** EYDENZELT
- **Generic name:** Aflibercept-Boav
- **Active ingredients:** AFLIBERCEPT-BOAV
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CELLTRION INC
- **First approval:** 2025-10-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761377)
---
*MORVS · CC0 1.0*